Contrarian Capital Management’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,091,118
Closed -$23.1M 14
2020
Q3
$23.1M Sell
3,091,118
-43,753
-1% -$376K 9.84% 3
2020
Q2
$27.1M Hold
3,134,871
9.54% 5
2020
Q1
$20.8M Sell
3,134,871
-277,296
-8% -$3.54M 10.91% 4
2019
Q4
$50.5M Buy
+3,412,167
New +$47.7M 6.19% 5
2019
Q2
Sell
-3,360,490
Closed -$86.8M 33
2019
Q1
$86.8M Buy
3,360,490
+15,221
+0.5% +$421K 7.72% 6
2018
Q4
$81.8M Buy
3,345,269
+7,964
+0.2% +$216K 7.63% 4
2018
Q3
$96.3M Buy
3,337,305
+113,446
+4% +$3.22M 8.48% 4
2018
Q2
$83.8M Buy
3,223,859
+363,092
+13% +$9.37M 7.53% 3
2018
Q1
$82.9M Buy
2,860,767
+57,966
+2% +$1.69M 7.83% 3
2017
Q4
$73.6M Buy
2,802,801
+246,597
+10% +$7.04M 7.19% 4
2017
Q3
$68.4M Buy
2,556,204
+396,895
+18% +$9.75M 8.38% 4
2017
Q2
$44.7M Buy
2,159,309
+87,992
+4% +$1.82M 8.68% 3
2017
Q1
$42.2M Buy
2,071,317
+200,000
+11% +$4.21M 11.69% 3
2016
Q4
$39.7M Buy
1,871,317
+1,748,617
+1,425% +$30.9M 10.14% 3
2016
Q3
$1.89M Buy
+122,700
New +$1.61M 0.9% 20

Other funds holding BAK

Contrarian Capital Management's BAK Position: Q4 2020 in Review

Contrarian Capital Management sold out of Braskem (BAK) in Q4 2020, closing a stake of 3,091,118 shares — an estimated $23.1M sold.

Contrarian Capital Management first reported a position in BAK in Q3 2016 and held it in 15 quarters. The position peaked at $96.3M in Q3 2018. 34 funds tracked by Wall St. Rank hold BAK as of Q4 2020.

  • Contrarian Capital Management reported no remaining Braskem position as of Q4 2020 after selling out during the quarter.
  • Contrarian Capital Management sold 3,091,118 Braskem shares in Q4 2020, an estimated $23.1M.
  • Contrarian Capital Management first reported a position in Braskem in Q3 2016 and held it in 15 quarters.
  • Contrarian Capital Management's Braskem position peaked at $96.3M in Q3 2018.
  • 34 funds tracked by Wall St. Rank held Braskem as of Q4 2020.

Based on Contrarian Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.